axitinib,sunitinib,pembrolizumab,nivolumab,ipilimumab
bms,merck,pfizer
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cm214', 'kn426']
many censoring patients at the tail of the curves, but the 36 months pfs landmark seems inferior than kn426 and cm214 for itt population #gu23 
Scientific Committee Member LACOG - GU. Medical Oncologist at Hospital Albert Einstein and CPO. Owner and founder BIO. Following or RT does not mean endorsement